Chemotherapy of Breast Cancer: Can We Improve Outcome and Decrease Toxicity by Tailoring Therapy?

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.1, Iss.3, 2002-03, pp. : 165-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Tailoring treatment to patients with early breast cancer - can we deliver?

By Gui Gerald

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 69-71

Informa Healthcare

Access to resources Recommend Favorite

How can we improve survival from breast cancer in developing countries?

By Sankaranarayanan Rengaswamy Alwan Nada Denny Lynette

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 179-183

Future Medicine

Access to resources Recommend Favorite

Development of targeted therapies for triple-negative breast cancer: can we harness tumor heterogeneity to improve patient outcomes?

By Diamond Jennifer R Elias Anthony D

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 175-178

Future Medicine

Access to resources Recommend Favorite

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

By Straver M.

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2411-2418

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy or Endocrine Therapy for Metastatic Breast Cancer?

By Wilcken Nicholas Hornbuckle Joanne Ghersi Davina

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 53-56

Springer Publishing Company

Access to resources Recommend Favorite